Jakob Krause Haaber

Company: SNIPR Biome

Job title: Vice President, CRISPR & Delivery Technologies

Seminars:

Gaining Insights into Clinical Testing of Engineered Phage Cocktail Targeting E. coli 2:00 pm

Revealing clinical results from Phase I trial on orally dosed, CRISPR-armed phage designed for precision killing of E. coli Improving safety, tolerability, and microbiological efficacy endpoints for superior patient results Consolidating the next steps in development and success of CRISPR-led phage therapyRead more

day: Day One